NASDAQ OMX

CTG Announces Application Advantage(TM) Solution Portfolio

Dela

Expands the availability of application portfolio management and help desk services across all industries and geographies served by the Company; reports results from current clients

BUFFALO, N.Y., May 16, 2017 (GLOBE NEWSWIRE) -- CTG (NASDAQ:CTG), a leading provider of information technology (IT) solutions and services in North America and Western Europe, announced today the formal launch of Application AdvantageTM to companies in all industries and geographies served by the Company. Recently developed as part of the Company's ONE CTG initiative, Application Advantage consolidates several existing services into a new, comprehensive solution that is designed to maximize the value, efficiency, and cost-effectiveness of the application management services it provides.

CTG's Gary Mann, Managing Director and Solution Owner, Application Advantage, commented, "I've been in the application management business for more than 35 years, and our clients in this space are facing more challenges than ever. Cloud networks, virtualization, multi-lingual support, and complexity of applications are all examples of the many issues pushing our clients' IT organizations to their limit. In this environment, the imperatives to reduce costs and improve IT team productivity have become critically important."

Mann continued, "Application Advantage is helping CTG clients work through these challenges in order to achieve the results their teams are expected to deliver. The solution is demonstrating real results for CTG clients across our served markets, including average first call resolution rates over 90 percent, call abandonment rates below five percent, and a speed to answer calls under 30 seconds-all while committing to helping our clients reduce costs."

Modular by design for added flexibility, Application Advantage helps CTG's clients maximize the value of enterprise applications through a suite of integrated assessment and roadmap, application management, and help desk services. These services help CTG clients meet their evolving business and technology needs, while reducing operational costs, creating scalable workforce capacity, improving technology as well as process efficiencies, and increasing end-user satisfaction. Services in the portfolio include:

  • Assessment and Roadmap: Leveraging Information Technology and Infrastructure Library (ITIL) and industry best practices as benchmarks, this comprehensive assessment results in a complete Report of Findings and a Performance Improvement Roadmap, which address operational processes and optimization possibilities, IT outsourcing strategy, and other opportunities based on the organization's application management and support model.
  • Application Management: Tier 2 and 3 services ensure 24x7 support for some, or all, of an organization's application portfolio by providing analysts and technicians with the technical, application, and in some cases specialized, knowledge necessary to provide troubleshooting capabilities beyond Tier 1. Designed to augment CTG's client resources, Tier 2 and 3 services are scalable to accommodate any size organization or effort.
  • Help Desk: Experienced Tier 1 help desk analysts provide "first line of defense" incident and request resolution in order to quickly and efficiently address end-user calls and improve first call resolution. Reliable help desk services allow CTG's client organizations to focus their in-house analysts' attention on more critical projects and optimization efforts.

Application Advantage engagements include dedicated account management, service level reporting, continuous process improvement initiatives, and regular quality monitoring. Additional value-add services are recommended for every project, based on client need, and can include offerings such as legacy data archiving support and access to CTG's private cloud-based network. Application Advantage offers multiple delivery approaches and provides location versatility in order to address the unique needs of each client. Delivery models currently include offshore and onshore options, while also providing 24x7 or on-demand support. Additionally, delivery of CTG's services can be decentralized/virtual, collocated, centralized on client site or in one of CTG's delivery centers, or a blended model.

"Application Advantage demonstrates our ongoing commitment to the development of industry-leading IT solutions that draw upon CTG's wide range of capabilities to help our clients meet the challenges facing their organizations and industries. It also underscores our progress in expanding our existing solutions across all lines of business-a key initiative of CTG's three-year strategic plan," said Bud Crumlish, CTG President and Chief Executive Officer.

"By building out and formalizing our expertise in areas that deliver high-value, reliable results for our clients, we are demonstrating our continued commitment to expanding our expertise in new ways that provide increased benefits to our clients," Crumlish continued.

For more information about Application Advantage, visit www.ctg.com/application-advantage or email solutions@ctg.com.

About CTG:
Over the last three decades, CTG has provided reliable IT solutions and services to more than 165 application management and help desk clients, and has supported more than 900 applications for clients in 45 countries. Delivered by expert analysts and application specialists, CTG's teams provide dependable, high-quality management, maintenance, and support for both legacy and current production applications, including specialized help desk offerings that meet the unique needs of companies in various industries, including manufacturing, energy, government, healthcare and life sciences, telecommunications, and financial services. CTG's help desk analysts currently provide support in seven languages. CTG has operations in North America, Western Europe, and India. The company regularly posts news and other important information online at www.ctg.com.

Safe Harbor Statement
This document contains certain forward-looking statements concerning the Company's current expectations as to future growth, financial outlook, business strategy and performance expectations for 2017 and three-year performance targets, a share repurchase program, and statements related to cost control, new business opportunities, financial performance, market demand, and other attributes of the Company. These statements are based upon the Company's expectations and assumptions, a review of industry reports, current business conditions in the areas where the Company does business, feedback from existing and potential new clients, a review of current and proposed legislation and governmental regulations that may affect the Company and/or its clients, and other future events or circumstances. Actual results could differ materially from the outlook guidance, expectations, and other forward-looking statements as a result of a number of factors, including among others, the availability to the Company of qualified professional staff, domestic and foreign industry competition for clients and talent, increased bargaining power of large clients, the Company's ability to protect confidential client data, the partial or complete loss of the revenue the Company generates from International Business Machines Corporation (IBM) and/or SDI International (SDI), the uncertainty of clients' implementations of cost reduction projects, the effect of healthcare reform and initiatives, the mix of work between staffing and solutions, currency exchange risks, risks associated with operating in foreign jurisdictions, renegotiations, nullification, or breaches of contracts with clients, vendors, subcontractors or other parties, the change in valuation of capitalized software balances, the impact of current and future laws and government regulation, as well as repeal or modification of such, affecting the information technology (IT) solutions and staffing industry, taxes and the Company's operations in particular, industry and economic conditions, including fluctuations in demand for IT services, consolidation among the Company's competitors or clients, the need to supplement or change our IT services in response to new offerings in the industry or changes in client requirements for IT products and solutions and other factors that involve risk and uncertainty including those listed in the Company's reports filed with the Securities and Exchange Commission as of the date of this document. Such forward-looking statements should be read in conjunction with the Company's disclosures set forth in the Company's 2016 Form 10-K, which is incorporated by reference, and other reports that may be filed from time to time with the Securities and Exchange Commission. The Company assumes no obligation to update the forward-looking information contained in this release.

ctg-g

Investors: John Laubacker
Chief Financial Officer
john.laubacker@ctg.com
(716) 887-7368

Media: Amanda LeBlanc
Vice President, Marketing
amanda.leblanc@ctg.com 
(225) 772-8865




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Computer Task Group, Incorporated via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference21.11.2017 15:15Pressmeddelande

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Peter Wrighton-Smith, Chief Executive Officer, will present at the 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28th, at 12:00 p.m. EST. The conference will be held at the Lotte New York Palace. A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.oxfordimmunotec.com. A webcast replay will be available approximately two hours after the live presentation and will be archived on the website for approximately 90 days. About Oxford Immunotec Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and comme

OmniComm Systems Signs Letter of Intent to Acquire Certain Assets of Algorithm and its Subsidiary Algorics21.11.2017 14:00Pressmeddelande

Acquisition Will Expand OmniComm's Product Line With Data Analytics and Risk-Based Monitoring Solutions FORT LAUDERDALE, Fla., Nov. 21, 2017 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology, and  Algorithm, Inc. and its subsidiaries Algorics Ltd. and Algorithm Informatics Pvt. Ltd. (collectively, "Algorics"), have signed a letter of intent ("LOI"), under which OmniComm will acquire certain assets and assume certain liabilities of Algorics, a provider of clinical analytics solutions and software. By combining forces, the companies expect increased operating efficiency, strengthened traction in the maturing risk-based approach solution area, new marketing opportunities and an expanded portfolio of electronic data capture (EDC) solutions for the global clinical trials industry. The transaction would also provide OmniComm with an office in India, a country of growing importance in t

CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs21.11.2017 14:00Pressmeddelande

SANTA CLARA, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the publication of two new papers. These joint publications illustrate the utility of Crown Bioscience's proprietary FATZO model as a model for obesity and type 2 diabetes in preclinical studies. The research conducted by Crown Bioscience, Eli Lilly and Company and Ball State University was published in two PLOS ONE papers: Peterson et al. Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco model PLOS One 2017;12 (6):e0179856, https://doi.org/10.1371/journal.pone.0179856  Droz et al. Correlation of disease severity with body weight and high fat diet in the FATZO/Pco model PLOS One 2017;1

Port Moresby Stock Exchange (POMSoX) Launches New Nasdaq Trading System21.11.2017 11:31Pressmeddelande

NEW YORK and PORT MORESBY, Papua New Guinea, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Nasdaq Inc. (NASDAQ:NDAQ) and the Port Moresby Stock Exchange (POMSoX) have announced that POMSoX has gone live with the widely deployed Nasdaq Matching Engine that operates on the Nasdaq Financial Framework platform. The launch of the new trading platform is a result of an upgrade from previous Nasdaq trading technology. The new trading engine will handle the trading of equities in the Papua New Guinea market. POMSoX has been a customer of Nasdaq since 1999.  "The Nasdaq trading platform will allow significant innovation in terms of market design and market offerings," said Johnson Kalo, a POMSoX board member said. "We believe the platform will provide strong support for future growth in the PNG market and provide new business opportunities in areas such as market data distribution." "We are pleased to continue to support POMSoX, a longstanding Nasdaq customer," said Robert Frojd, Regional Man

CloudCraze Joins the Pledge 1% Movement, Makes Commitment to Philanthropic Leadership21.11.2017 08:00Pressmeddelande

CloudCraze will leverage profit and employee time to improve communities around the world LONDON, Nov. 21, 2017 (GLOBE NEWSWIRE) -- CloudCraze, the enterprise B2B commerce platform built natively on Salesforce, has joined Pledge 1%, a corporate philanthropy movement dedicated to making the community a key stakeholder in every business. Spearheaded by Atlassian, Rally, Salesforce and Tides, Pledge 1% empowers companies to donate 1% of product, 1% of equity, 1% of profit or 1% of employee time to improve communities around the world. CloudCraze is joining an impressive network of entrepreneurs and companies across the globe that have committed to philanthropic efforts through the Pledge 1% movement. By pledging 1% of its profit and employee time, CloudCraze is demonstrating a commitment to philanthropic leadership. "We are incredibly excited that CloudCraze has taken the pledge," said Amy Lesnick, chief executive of Pledge 1%. "CloudCraze can play a pivotal role i

HemChecks avläsare kalibrerad med toppresultat - Regulatorisk20.11.2017 16:18Pressmeddelande

HemChecks avläsare kalibrerad med toppresultat Det medicintekniska bolaget HemCheck, som utvecklar ett patientnära test för detektion av hemolys, kan idag meddela att den digitala avläsare som utgör en del av bolagets produktkoncept Helge, kalibrerats med mycket gott resultat. Detta skedde genom studier i egen regi. Avläsaren kan nu färdigställas och produktkonceptet kommer därmed ett steg närmare CE-märkning. Som ett led i att färdigställa bolagets produktkoncept Helge har HemCheck under hösten utfört studier i egen regi med hjälp av blod från frivilliga bloddonatorer. Syftet var att kalibrera avläsaren och på så sätt möjliggöra en patientnära avläsning av hemolys, det vill säga redan på ett tidigt stadium avgöra om blodprovet är användbart och kan ska skickas till analys.   -Enkelt utryckt har vi lärt avläsaren att mäta hemolys på våra engångstester. Det är en viktig milstolpe och en stor framgång. Nu känner vi oss redo

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum